Dr Reddy's Laboratories update on patent litigation for Buprenorphine and Naloxone Sublingual Film

Image
Capital Market
Last Updated : Jun 29 2018 | 11:04 AM IST
Dr Reddy's Laboratories has provided update on patent litigation with respect to generic Buprenorphine and Naloxone Sublingual Film in the U.S. Market.

The Judge has heard the matter on 28 June 2018 and extended the temporary restraining order for a further period of 14 days pending his decision.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jun 29 2018 | 10:47 AM IST

Next Story